BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27461224)

  • 1. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
    Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
    Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
    Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
    Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Response Assessed by Contrast-Enhanced Ultrasound in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
    Dong T
    Ultrasound Q; 2018 Jun; 34(2):84-87. PubMed ID: 29420367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
    J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
    Cao X; Xue J; Zhao B
    Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
    Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
    Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can unenhanced MRI of the breast replace contrast-enhanced MRI in assessing response to neoadjuvant chemotherapy?
    Cavallo Marincola B; Telesca M; Zaccagna F; Riemer F; Anzidei M; Catalano C; Pediconi F
    Acta Radiol; 2019 Jan; 60(1):35-44. PubMed ID: 29742918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.
    Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF
    Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-quadrant fast compressive tracking of breast ultrasound videos for computer-aided response evaluation of neoadjuvant chemotherapy in mice.
    Yan Y; Tang L; Huang H; Yu Q; Xu H; Chen Y; Chen M; Zhang Q
    Comput Methods Programs Biomed; 2022 Apr; 217():106698. PubMed ID: 35217304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos.
    Zhang Q; Yuan C; Dai W; Tang L; Shi J; Li Z; Chen M
    Phys Med; 2017 Jul; 39():156-163. PubMed ID: 28690116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new algorithm for automatic vascular mapping of DCE-MRI of the breast: Clinical application of a potential new biomarker.
    Vignati A; Giannini V; Carbonaro LA; Bertotto I; Martincich L; Sardanelli F; Regge D
    Comput Methods Programs Biomed; 2014 Dec; 117(3):482-8. PubMed ID: 25262335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.
    Amioka A; Masumoto N; Gouda N; Kajitani K; Shigematsu H; Emi A; Kadoya T; Okada M
    Jpn J Clin Oncol; 2016 Apr; 46(4):303-9. PubMed ID: 26848078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Evaluation of Relative Changes in Tumor Stiffness by Shear Wave Elastography Predicts the Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
    Jing H; Cheng W; Li ZY; Ying L; Wang QC; Wu T; Tian JW
    J Ultrasound Med; 2016 Aug; 35(8):1619-27. PubMed ID: 27302898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
    Peng J; Pu H; Jia Y; Chen C; Ke XK; Zhou Q
    Medicine (Baltimore); 2021 May; 100(19):e25908. PubMed ID: 34106653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):552-62. PubMed ID: 18398094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
    Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
    Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
    Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Flow Characteristics in Three-Dimensional Power Doppler Ultrasound Imaging to Predict Complete Responses in Patients Undergoing Neoadjuvant Chemotherapy.
    Shia WC; Huang YL; Wu HK; Chen DR
    J Ultrasound Med; 2017 May; 36(5):887-900. PubMed ID: 28109009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.